Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 03, 2024 23:30 ET | Source: Transparency Market Research

Onco-hematology Molecular Testing Market Size to Reach USD 1.5 billion by 2031 with a 12.5% CAGR, Boosted by Next-Generation Blood Cancer Diagnostics| Exclusive Report by Transparency Market Research, Inc.

Wilmington, Delaware, United States, Transparency Market Research, Inc., Oct. 03, 2024 (GLOBE NEWSWIRE) -- According to a report published by Transparency Market Research, the global onco-hematology...
May 22, 2023 11:00 ET | Source: Precipio, Inc.

Precipio’s Lab Detects BCR-ABL1 Oncogene Co-Expression of p190 & p210 Isoforms in a CML Patient By Using HemeScreen® Technology

NEW HAVEN, Conn., May 22, 2023 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. leveraged its proprietary HemeScreen technology as part of the diagnostic process to monitor a...
March 23, 2023 06:00 ET | Source: DelveInsight Business Research LLP

Chronic Myeloid Leukemia Market to Exhibit Significant Growth as Leading Companies Such as Novartis, Ascentage Pharma, Terns Pharmaceuticals, Sanofi, and Others are Exploring the Domain | DelveInsight

New York, USA, March 23, 2023 (GLOBE NEWSWIRE) -- Chronic Myeloid Leukemia Market to Exhibit Significant Growth as Leading Companies Such as Novartis, Ascentage Pharma, Terns Pharmaceuticals,...
May 23, 2022 13:00 ET | Source: DelveInsight Business Research LLP

Global Chronic Myeloid Leukemia Pipeline Insight | Clinical Trials Evaluation Research Report 2022 by DelveInsight

Las Vegas, USA, May 23, 2022 (GLOBE NEWSWIRE) -- Global Chronic Myeloid Leukemia Pipeline Insight | Clinical Trials Evaluation Research Report 2022 by DelveInsight Chronic Myeloid Leukemia...
April 08, 2022 09:10 ET | Source: CMI

Global Chronic Myeloid Leukemia Treatment Market to Surpass US$ 10,864.9 Million by 2028, Says Coherent Market Insights (CMI)

SEATTLE, April 08, 2022 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global chronic myeloid leukemia treatment market is estimated to be valued at US$ 7,216.3 million in 2021, and...
November 13, 2018 00:00 ET | Source: MolecularMD

First quantitative diagnostic test validated for Treatment-Free Remission for Eligible Patients with Ph+ CML-CP Treated with Tasigna® Cleared by Health Canada

PORTLAND, Ore. and CAMBRIDGE, Mass., Nov. 13, 2018 (GLOBE NEWSWIRE) -- MolecularMD Corporation received regulatory approval from Health Canada for the MRDx® BCR-ABL Test, a quantitative diagnostic...